Does SECUKINUMAB Cause Flushing? 192 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Flushing have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
192
Reports of Flushing with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
1
Deaths
41
Hospitalizations
How Dangerous Is Flushing From SECUKINUMAB?
Of the 192 reports, 1 (0.5%) resulted in death, 41 (21.4%) required hospitalization, and 22 (11.5%) were considered life-threatening.
Is Flushing Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 192 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which SECUKINUMAB Alternatives Have Lower Flushing Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG